Biologics company sells shares, registers with SEC
Harpoon offers to sell shares of its common stock in its proposed IPO after registering a statement with the SEC while developing T-Cell engagers.
Archives for January 4, 2019
China boasts second domestically developed PD-1 approval
Eli Lilly and Innovent announced that their jointly developed anti-PD-1 drug gained approval in China, becoming the second domestically produced treatment of this type.